Breaking News - Polaris International Holdings, Inc. (OTCPINK:
PIHN) -
April 22, 2014
Polaris International Holdings Enters Joint Venture for
Kentucky Hemp Project
"With Kentucky's SB50 becoming law and
allowing the growth of hemp, the opportunity to secure farmland for our benefit
was necessary."
PLANO, TX – April 22, 2014 Polaris International Holdings, Inc. (OTCPINK:
PIHN) has entered into a
revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement
provides for Polaris to secure 100% of the harvested material for the extraction
of cannabinoids.
Polaris is focused on the development of their ProCannas Product line and
intends on utilizing some of the production of Hemp to be used for the
production of such said line of products and the availability to enter into
other markets as well.
The two companies will form a separate LLC of which each company will be
members.
Kentucky passed SB50 in 2013 which removes hemp from the controlled substances
list and allows for Kentucky farmers to cultivate the crop without fear of law
enforcement. To read the entire bill visit http://www.lrc.ky.gov/record/13RS/SB50.htm
"With Kentucky's SB50 becoming law and allowing the growth of hemp, the
opportunity to secure farmland for our benefit was necessary. By entering this
joint venture, we are opening the door to establish our own supply of CBD for
use in our ProCannas products. This will substantially reduce our production
costs and therefore increase profitability for the Company." states Medical
Director, Dr. Vasthi Alvarez Avila. Tentative plans for extraction of the CBDs
from the growth production will be completed within Kentucky which will decrease
delivery and production time.
The Company is also looking forward to the launch of its new website in the
coming weeks which will have more detailed information on the company,
production, and the ProCannas line of products.
ABOUT THE COMPANY
ProCannas core business focuses on the manufacture and distribution of new,
pharmaceutical grade cannabinoid based products for medicinal use. Due to the
concentrated strength and unique mix of ingredients integrated within our
products, they are intended to be available to patients only through licensed
participating physicians. Due to recent changes in the law regarding the medical
use of marijuana, coupled with studies and a strong body of evidence
highlighting that THC is not the significant component for medicinal use, doors
are opening for innovation. Laws are expected to become even more favorable for
companies like ProCannas. The Company intends to target a broad range of
specialties with this novel product, including but not limited to sports
medicine, pain management, neurology, and osteopathic medicine.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future
anticipated projected plans, performance and developments, intended to qualify
for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. Any statements on this news release that are not
statements of historical fact should be considered forward-looking statements.
These forward-looking statements generally can be identified by phrases such as
"believes," "expects," "anticipates," "foresees," "forecasts," "estimates,"
"intends," or other words or phrases of similar import. Similarly, statements in
this news release that describe the Company's business strategy, outlook,
objectives, plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from those in
forward-looking statements.
Investor Inquiries:
Polaris International Holdings, Inc.
WWW.Procannas.net
970-279-3478
Info@Procannas.net">Info@Procannas.net
SOURCE: Polaris International Holdings, Inc.
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates
electronic information through multiple online media channels. FNMG's intended
purposes are to deliver market updates and news alerts issued from private and
publicly trading companies as well as providing coverage and increased awareness
for companies that issue press to the public via online newswires. FNMG and its
affiliated companies are a news dissemination and financial marketing solutions
provider and are NOT a registered broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to sell or offer to buy any
security. FNMG's market updates, news alerts and corporate profiles are NOT a
solicitation or recommendation to buy, sell or hold securities. The material in
this release is intended to be strictly informational and is NEVER to be
construed or interpreted as research material. All readers are strongly urged to
perform research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG was ompensated three thousand five hundred dollars for
this
Polaris International Holdings, Inc.
news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF
Polaris International Holdings, Inc.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|